Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations

WCVB News 5
|

Ultra-sensitive Simoa technology powers a new COVID-19 antibody test that can detect antibodies at 1000x lower concentrations. Quanterix CEO Kevin Hrusovsky and Dr. David Walt, a developer of the technology, discuss how the test provides insight into the earliest stages of immune response and can help hospitals measure antibodies in patient samples with unprecedented specificity.

WATCH THE VIDEO

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more